Heartbreaking Diagnosis: UK Mum Scrambles Against Time After Son, 4-Years-Old, Is Found to Have Devastating Genetic “Childhood Dementia” Disorder
In Swansea, South Wales, a mother named Tammy McDaid is fighting with every fibre of her being after discovering that her bubbly, energetic four-year-old son, Tate, is not simply a boy full of life and laughter — he is confronting a diagnosis few families face and even fewer comprehend. What began as hopes for a happy childhood has now turned into a tense and urgent race against time. Tate was initially diagnosed at age two with autism, but as Tammy sensed in her heart, something more profound was at play. An MRI undertaken in March 2024 revealed abnormal spaces in his brain — a harrowing indicator of neuro-degeneration. Further testing confirmed the diagnosis: Sanfilippo syndrome Type A, sometimes referred to as a form of “childhood dementia”. According to PEOPLE Magazine reporting, and later verified through Cleveland Clinic literature and rare disease registries, Tate is one of only a tiny number of children in the United Kingdom diagnosed with this brutal disorder.
Sanfilippo Type A is a rare genetic condition in which essential enzymes that break down certain molecules in cells are missing. The result is a smooth but relentless decline in the brain’s ability to function, manifesting through worsening cognitive, behavioural and physical decline. Cleveland Clinic explains the disease attacks the central nervous system and “leads to premature death.” For children with Type A like Tate, the expected lifespan is tragically short — often 11 to 19 years, with a rapid decline beginning in toddlerhood or early school age. There is no cure and no approved treatment to stop disease progression.
The moment Tammy saw the MRI results, the ground shifted beneath her life. She says she always knew something deeper was wrong. “Deep down I always suspected there was something more,” she told BBC Wales. Tate had never spoken a word, something she was initially told could be related to autism. She was encouraged to wait, to give him time, to let speech therapy work. But two years passed, and nothing changed. Now, the once-hopeful mystery makes painful sense. “My little boy has never spoken a word, and now I know I will never get to hear his voice,” she said in her campaign statement.
What followed was not paralysis but action. Tammy set up a GoFundMe page with a single mission: to buy her son more time. Tate’s form of the disease is progressive and unforgiving, but emerging clinical trials offer a sliver of hope — not to cure him, but to slow the decline. These treatments include experimental gene therapies and enzyme-replacement approaches currently running in select international medical centres. Many are not available through standard NHS pathways, and all require extensive funding for travel, assessment and ongoing treatment.
“This next year is quite critical in Tate’s life as it’s around now that things start to show,” she explains. The regression in Sanfilippo is often subtle at first — a child stops learning new skills, then gradually loses previously mastered ones. Motor skills decline. Feeding becomes difficult. Eventually, walking becomes impossible, seizures begin, and the disease takes everything. Tate, however, is still mobile, full of kinetic energy. “He could climb before he could walk. I just want him to be able to do this for as long as possible,” Tammy says. That ability, something most parents take for granted, is now a race against biology.
Every day matters. Every moment spent running and climbing is its own small act of defiance against the condition growing inside his cells. She describes how he expresses love without words — hugs, kisses, constant motion. “I am so blessed and proud of him. Even though he can’t talk, he hugs and kisses me.” Those simple gestures now carry the weight of all the words he may never say.
Sanfilippo syndrome, often described in media as “childhood dementia,” is so rare that public awareness remains limited. Its mechanics mimic Alzheimer’s — memory loss, personality change, physical decline — but the disease affects children. Parents must watch regression instead of growth. Specialists note that many children are misdiagnosed with autism at first, because early symptoms overlap: speech delays, behavioural differences, sensory issues. But then the deeper neurological signs appear, and by the time a diagnosis is confirmed, priceless years have been lost.
Even with clarity, the road forward is filled with logistical and emotional challenges. Clinical trial qualification isn’t automatic. Families must apply, pass eligibility screens, travel long distances and, in many cases, relocate temporarily. Time is the true enemy. The earlier a child begins therapy, the more function can be preserved. For Tate, every month without intervention increases the risk of irreversible degeneration.
Tammy’s determination is unwavering. Her fundraiser describes how every pound raised will go toward “exploring any possible treatment options abroad … these potential trials or therapies could give him more time being mobile & eating food! More days filled with climbing, running, and me living on edge to see where he will escape to next!” It is a sentence full of heartbreak — and full of love. Her rallying cry is not for a miracle but for a fighting chance.
Behind her emotional plea is also a harsh reflection of global rare-disease reality: the rarity of a disorder often determines how quickly medicine advances. With only a handful of known cases, researchers struggle to secure funding, pharmaceutical companies lack incentive to produce drugs, and governments rarely prioritise development. That leaves parents like Tammy acting as full-time advocates, fundraisers and coordinators while also caring for a medically fragile child.
Yet, within this isolating experience, she has found community. Other parents of Sanfilippo children have reached out online. Some share advice about home adaptations, swallowing therapy, seizure education, night monitoring. Others simply offer solidarity — a voice saying, “You’re not alone.” For most families, that becomes as important as medical strategy. There is no day off. No mental respite. But there is shared strength.
Tammy has also taken on the role of educator, using podcasts, local press and social media to spread awareness. She knows that even if a cure does not come in time for her son, awareness today fuels research tomorrow. Many rare diseases that were once neglected have treatments now because families refused to stay silent.
Doctors caution that, statistically, the odds are still daunting. No currently available therapy stops Sanfilippo entirely. Some children enrolled in trials retain certain abilities longer than expected. Others decline more slowly. That extra time — even a year, even six months — is what parents fight for. The goal becomes quality of life: being able to walk a little longer, eat without assistance, stay present in moments of joy. For many families, those victories are worth the world.
In her interview, Tammy acknowledges that she grieves “the life she thought he would have.” The first day of school, sports, friendships, the tiny but beautiful sound of “Mum.” But she refuses to let grief eclipse hope. Her eyes remain fixed on the precious present — every laugh, every hug, every climb. “He is my world,” she says. “If I can give him one more summer of running free, I will.”
Stories like Tate’s are not just medical tragedies — they are calls to action. They remind the world how fragile childhood can be. How quickly a family can go from planning birthdays to decoding genetic reports. They challenge society to reconsider how research is prioritised, how healthcare systems support rare-disease families, and how compassion must be paired with real-world resources.
Tammy knows the world cannot give her back the dreams she once had. But she hopes it might help her keep her son’s future from shrinking too soon. Every donation, every share, every moment of awareness is, in her words, “time in the bank” — a little more life for Tate before the disease takes what it was never meant to steal.
There is a quiet, powerful dignity in that fight. And even without words, little Tate has become a voice — one speaking clearly about love, urgency and the value of every borrowed moment.
